Segment disclosures

Company overview

MEDICINOVA, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 11 retained observations 7 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reportable Segment Aggregation Before Other Operating Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30138555 USD20261112Open filing evidence
2026-01-01 – 2026-09-30783978 USD20261112Open filing evidence
2026-04-01 – 2026-06-30458439 USD20260813Open filing evidence
2026-01-01 – 2026-06-30645423 USD20260813Open filing evidence
2026-01-01 – 2026-03-31186984 USD20260514Open filing evidence
2025-01-01 – 2025-12-31409657 USD20260310Open filing evidence
2025-07-01 – 2025-09-30123319 USD20261112Open filing evidence
2025-01-01 – 2025-09-30257918 USD20261112Open filing evidence
2025-04-01 – 2025-06-30134599 USD20260813Open filing evidence
2025-01-01 – 2025-06-30134599 USD20260813Open filing evidence
2023-01-01 – 2023-12-311000000 USD20250219Open filing evidence